Comprehensive Hematology Oncology LLC: Company Profile

Background

Overview

Comprehensive Hematology Oncology LLC is a physician-led, patient-centered practice specializing in the diagnosis and treatment of cancer and blood disorders. Established in 1995 in St. Petersburg, Florida, the practice has expanded its services across the Tampa Bay area, including Pinellas, Hillsborough, Pasco, and Manatee Counties.

Mission and Vision

Mission: To provide expert, patient-focused care with advanced treatments and unwavering support.

Vision: To lead in innovative, comprehensive, and compassionate cancer care across Tampa Bay.

Industry Significance

With nearly three decades of trusted service, Comprehensive Hematology Oncology LLC has been a cornerstone of cancer and blood disorder care in the Tampa Bay area, offering personalized and compassionate care to a diverse patient population.

Key Strategic Focus

Core Objectives

Deliver personalized, compassionate care to patients with cancer and blood disorders.

Utilize advanced, evidence-based treatments to achieve optimal patient outcomes.

Expand access to specialized care across the Tampa Bay region.

Areas of Specialization

Medical Oncology: Treatment of various cancers using chemotherapy, immunotherapy, and targeted therapies.

Hematology: Diagnosis and management of blood disorders and blood cancers, including leukemia, lymphoma, and myeloma.

Radiation Oncology: Advanced radiation treatments tailored to individual patient needs.

Infusion Services: Administration of chemotherapy, immunotherapy, and IV treatments in a compassionate setting.

Clinical Trials and Research: Access to innovative clinical trials for advanced treatment options.

Key Technologies Utilized

State-of-the-art diagnostic imaging.

Advanced radiation therapy equipment.

On-site pharmacy services with home delivery options.

Clinical trial management systems.

Primary Markets Targeted

Residents of Pinellas, Hillsborough, Pasco, and Manatee Counties in Florida.

Patients seeking comprehensive cancer and blood disorder care.

Financials and Funding

Funding History

As a privately held entity, Comprehensive Hematology Oncology LLC has not publicly disclosed detailed financial information or funding history.

Recent Developments

In October 2023, the practice joined the Quality Cancer Care Alliance (QCCA), a national clinically integrated network of independent oncology and hematology practices. This collaboration aims to enhance research capabilities, streamline processes, and improve patient care through shared resources and data.

Pipeline Development

Clinical Trials and Research

Comprehensive Hematology Oncology LLC actively participates in clinical trials, providing patients with access to innovative treatment options and contributing to advancements in cancer and blood disorder therapies.

Technological Platform and Innovation

Proprietary Technologies

On-site pharmacy with home delivery services, ensuring timely access to medications.

Clinical trial management systems to facilitate patient enrollment and data collection.

Significant Scientific Methods

Evidence-based treatment protocols aligned with National Comprehensive Cancer Network (NCCN) guidelines.

Advanced diagnostic imaging techniques for accurate disease assessment.

Leadership Team

Key Executives

Dr. Pratibha Kirit Desai, MD: Founder and Managing Partner. Dr. Desai has been instrumental in establishing and expanding the practice, emphasizing patient-centered care and innovative treatment approaches.

Dr. Poorvi Kirit Desai, MD: Medical Oncologist and Hematologist. Dr. Poorvi Desai contributes to the clinical excellence of the practice, focusing on comprehensive cancer care.

Dr. Syed Hasan Abid, MD: Hematologist and Oncologist. Dr. Abid brings expertise in blood disorders and oncology, enhancing the practice's service offerings.

Dr. Sudhir J. Hansalia, MD: Medical Oncologist. Dr. Hansalia specializes in medical oncology, providing advanced treatment options to patients.

Dr. Kenneth Sherman Wurtz, MD: Hematologist. Dr. Wurtz offers specialized care in hematology, addressing a range of blood-related conditions.

Competitor Profile

Market Insights and Dynamics

The Tampa Bay area has a competitive healthcare landscape, with several institutions offering oncology and hematology services. Comprehensive Hematology Oncology LLC differentiates itself through its patient-centered approach, comprehensive service offerings, and commitment to compassionate care.

Competitor Analysis

Moffitt Cancer Center: A leading cancer research and treatment center in Tampa, offering extensive oncology services.

Florida Cancer Specialists & Research Institute: Provides comprehensive cancer care with multiple locations across Florida.

BayCare Health System: Operates several hospitals and outpatient centers offering oncology services in the Tampa Bay area.

Strategic Collaborations and Partnerships

Joining the QCCA network enhances Comprehensive Hematology Oncology LLC's capabilities in research, data management, and process optimization, positioning it to better compete in the market.

Operational Insights

Strategic Considerations

By focusing on personalized care, advanced treatment options, and patient support services, Comprehensive Hematology Oncology LLC maintains a competitive edge in the Tampa Bay healthcare market.

Competitive Advantages

Physician-led, patient-centered approach.

Comprehensive range of services under one roof.

Active participation in clinical trials, offering access to cutting-edge treatments.

Strategic Opportunities and Future Directions

Strategic Roadmap

Expand clinical trial offerings to provide patients with access to the latest therapies.

Enhance community outreach and education programs to raise awareness about cancer and blood disorders.

Strengthen partnerships within the QCCA network to leverage shared resources and expertise.

Future Business Directions

Comprehensive Hematology Oncology LLC aims to continue its growth by expanding service offerings, enhancing patient care, and contributing to advancements in cancer and blood disorder treatments.